Loading...
XSHE
002382
Market cap761mUSD
Jul 09, Last price  
5.13CNY
1D
-0.39%
1Q
-33.98%
Jan 2017
-57.85%
IPO
-45.81%
Name

Blue Sail Medical Co Ltd

Chart & Performance

D1W1MN
XSHE:002382 chart
P/E
—
P/S
0.90
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-1.01%
Rev. gr., 5y
-6.68%
Revenues
5.74b
-8.21%
516,652,774477,702,866621,540,628933,651,6221,333,379,9501,335,188,0191,535,087,4471,508,984,6861,288,770,7191,575,945,3082,653,120,0783,475,614,1547,869,425,1438,108,586,4648,108,586,4634,900,477,5694,900,477,5694,927,074,8626,253,168,2365,739,692,552
Net income
-759m
L+70.32%
61,357,95459,849,72440,334,40129,061,79751,197,42046,974,24161,701,870170,211,827181,069,387200,864,348346,714,037490,295,0921,758,477,2601,155,709,1911,155,709,1930-372,316,290-568,360,487-445,608,863-758,940,830
CFO
458m
+236.93%
12,009,32616,077,85175,913,94262,047,36500153,821,697133,891,561150,958,834261,299,378163,926,593227,567,253649,366,180782,789,0963,671,535,9962,245,545,736494,468,136-72,885,826135,849,276457,723,247
Dividend
May 31, 20230.4 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Blue Sail Medical Co.,Ltd. is a global enterprise based in Zibo, China, specializing in the production and distribution of a wide array of protective gloves. Its offerings include disposable medical, latex, nitrile, PVC, TPE, and household gloves, which are utilized across various sectors such as medical examination and protection, food processing, and the electronics industry. Beyond its glove business, the company actively engages in the research, development, manufacturing, and sales of cardiac stents and associated equipment for interventional cardiac surgery. Established in 2002, the company was formerly named Shandong Blue Sail Plastic & Rubber Co., Ltd. before adopting its current identity, Blue Sail Medical Co.,Ltd., in July 2014.
URL
http://www.bluesail.cn/
IPO date
Apr 02, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT